Introduction
In the complex field of gastrointestinal disease, a relatively recent discovery has revolutionized the understanding of digestive health. Microbiota is the collective term for the bacteria, fungi, and other microorganisms that live on or within humans. The microbiome is the collection of genes that are carried by the microbiota. The microbiota has a significant mutualistic, beneficial relationship with the person it inhabits. It has become clear that the gastrointestinal tract's dynamic and diverse ecology of microbes plays a key role in both health and sickness. Several human illnesses can arise from disruptions in the commensalism between the microorganisms and the host. Dysbiosis, or an imbalance in the microorganisms in the gut, is associated with several digestive problems. These changes in the microbiota are linked to conditions such as colorectal cancer, Inflammatory Bowel Disease (IBD), and irritable bowel syndrome (IBS). These illnesses are caused by inflammation that can be exacerbated by the microbiome's interaction with the gut lining.
What Are the Functions of Gut Microbiota?
-
Direct Inhibition of Pathogens: The gut microbiota acts as a barrier to keep the body safe from diseases. Furthermore, Microflora generates bacteriocins to prevent other bacteria from growing.
-
Digestion: Humans are not able to digest some types of carbohydrates, such as lactose, starches, or fibers. These carbohydrates are converted by bacteria in the large intestine into short-chain fatty acids (SCFA), such as butyric, propionic, and acetic acid. Propionate promotes the generation of ATP in the liver and inhibits hunger signals. By enabling dangerous cells to self-destruct and giving intestinal cells energy, butyrate helps prevent colon cancer. Acetic acid is used by muscles, and the fermentation produces hydrogen and carbon dioxide as well as other, less odorous gasses.
-
Metabolism: In addition to producing a variety of vital vitamins for life, gut bacteria are also capable of synthesizing all amino acids, both necessary and nonessential, and converting bile. A microbial population may produce a wide range of water-soluble and fat-soluble vitamins, including vitamin K and folic acid (B9), riboflavin (B2), biotin (B7), cobalamin (B12), nicotinic acid (B3), pantothenic acid (B5), and thiamine (B1). Additionally, it facilitates the absorption of minerals, including calcium, iron, and magnesium.
-
Immune System Development: Some dietary ingredients are fermented by gut bacteria, and the resultant SCFA causes a significant increase in neutrophil, basophil, and eosinophil production. There are some receptors in the intestinal epithelium. These receptors recognize and attach to certain molecules linked to bacteria, triggering the production of white blood cells, protective peptides, and cytokines as part of the host immune response. Any change to a healthy microbiome might cause the immune system to become hyperactive or underactive. The generation of antibodies is regulated by gut microbiota, which further promotes the conversion of B cells into IgA cells. One crucial antibody for the mucosal gut environment is IgA. To maintain healthy gut bacteria and the host environment, IgA contributes to the variety of gut microflora and aids in the removal of bacteria that cause inflammation.
-
The Gut-Brain Axis: The central nervous system, the neuroendocrine and neuroimmune systems, including the hypothalamic-pituitary-adrenal (HPA) axis, the sympathetic and parasympathetic arms of the autonomic nervous system, which include the enteric nervous system, the vagus nerve, and the gut microbiota, are all included in the gut-brain axis.
A recent study suggests that colonocyte cells, also known as colonic epithelial cells, assist the host in preserving the homeostasis of the gut microbiota by sustaining their oxidative metabolic stress and consuming large amounts of oxygen, which creates anaerobic conditions in the gut lumen. A high-fat diet's effects on the anaerobic state of the gut lead to hydrogen peroxide synthesis in the mitochondria, which in turn causes mitochondrial malfunction. Although the exact process is uncertain, reactive oxygen species production from mitochondrial failure also results in dysbiosis.
What Are the Human Diseases Caused by Gut Microbiota?
A condition known as "dysbiosis" is characterized by certain alterations in the human microbiome. Enough research has been done to demonstrate that dysbiosis of the gut microbiota is the root cause of several illnesses, such as gastrointestinal issues, obesity, cardiovascular disease, and disorders relating to the central nervous system.
-
Inflammatory Bowel Disease (IBD): IBD, which includes ulcerative colitis and Crohn's disease, highlights the complex interplay between gut pathology and microbiota. In IBD patients, dysbiosis is characterized by a reduction in the number of helpful bacteria and a rise in potentially hazardous microorganisms, which exacerbates chronic inflammation.
-
Irritable Bowel Syndrome (IBS): This functional gastrointestinal illness shows changes in the composition of the gut microbiota. Symptoms include bloating, irregular bowel habits, and stomach discomfort, which may be brought on by imbalances among specific bacterial populations. Understanding these microbial changes is essential to developing targeted therapies.
-
Gastrointestinal Malignancies: A recent study indicates a connection between gastrointestinal malignancies and gut flora. The development and progression of colorectal cancer may be influenced by certain microbial communities, which highlights the necessity of investigating microbiome-based approaches for cancer prevention and therapy.
-
Metabolic Disorders:
-
Obesity: The composition of the gut microbiota is greatly impacted by the food consumed. A high-fat diet modifies the gut microbiota. The gut microbiota or its metabolites that control the microbiota-brain-gut axis have an impact on obesity by causing chronic inflammation.
-
Liver Diseases: Drinking too much alcohol can harm the liver, and this is connected to an imbalance in the gut bacteria. The damage might happen because of harmful substances from bacteria and their products, leading to alcohol-related liver issues and a condition called alcohol-induced endotoxemia.
-
Diabetes: An imbalance in gut bacteria, called dysbiosis, can cause metabolic problems and is directly connected to issues like obesity, fatty liver disease, and diabetes. Changes in the usual gut bacteria can affect the liver, making it more permeable to bacteria and their by-products. This triggers the immune system, causing inflammation and leading to health problems, including diabetes.
-
Cardiovascular Diseases: Cardiovascular illnesses, such as atherosclerosis (acute coronary syndrome and stroke), heart failure, and hypertension. An imbalance in gut bacteria, known as dysbiosis, can reduce the production of butyrate. This can result in problems like inflammation, which leads to the adhesion of immune cells and the development of plaque in arteries, causing a condition called atherosclerosis. This increases the risk of cardiovascular disease.
-
Neurological Disorders: The gut microbiota plays a crucial role in neurological health, influencing brain function and potentially contributing to disorders like Alzheimer's and depression.
Conclusion
The complex interplay between gastrointestinal health and the human gut microbiota is a rapidly evolving field with significant implications for many facets of well-being. Essential roles played by the gut microbiota include digestion, metabolism, immune system development, and gut-brain axis influence. A variety of human illnesses, including gastrointestinal cancers, metabolic problems, cardiovascular diseases, neurological disorders, inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS), have been related to dysbiosis, an imbalance in gut microbes. Comprehending how dysbiosis affects various ailments is essential to creating focused treatment strategies. The gut microbiome is emerging as a key component in sustaining health or contributing to a range of illnesses, from affecting chronic inflammation in IBD to impacting the progression of obesity, liver diseases, diabetes, cardiovascular diseases, and neurological disorders. Prospective investigations and therapeutic measures targeted at modifying the gut microbiota exhibit the potential to progress prophylactic and remedial approaches, thus revolutionizing the field of gastrointestinal disease and human health.
